1/10/2022 | 3002419000 | INJECTABLE SUSPENSION, GARDASIL, S/M PHARMACEUTICAL PRODUCT / ACT PRINCIPLE: HUMAN PAPILLOMA VIRUS TYPE 6, 11,16,18 MEDICINE FOR HUMAN USE / ORDER: 6000554517 BOX X1 BOTTLE, LOT: U034657 MFG DATE: 22.05.2021 EXP DATE: 22.05.2024 GARDASIL 0.5ML 1DOSE | 29.932 | KG | 34678.19 | Peru | AMSTERDAM | MERCK SHARP & DOHME INTERNATIONAL | Get Detailed Shipment Records
|
1/25/2022 | 3002419000 | LYOPHILIZED POWDER, ONCOTICE, S/M PHARMACEUTICAL PRODUCT (ONCOLOGICAL PRODUCT) MEDICATION FOR HUMAN USE / ACTIVE PRINCIPLE:BCG, CEPA TICE BOX X 1 VIAL, LOT: U039925, MFG DATE: 06.18.2021 EXP DATE:12.16.2022 ONCOTICE 12.5MG /ML 2ML 1 VIAL PER 1961014,N° P | 8.4 | KG | 11949.085 | Peru | AMSTERDAM | MSDIS OSS PHARMA-OPS |
1/10/2022 | 3002419000 | MENACTRA, MENACTRA, S/M INJECTABLE SOLUTION // LOT: U7304AB - 06/15/2023 // BOX X 1 VIAL WITH 0.5ML USE: VACCINE ANTI-MENINGOCOCCAL POLYSACCHARIDE CONJUGATED WITH DIPHTHERIA TOXOID 284 MENACTRA 1V_1D XES NEUTRAL INT 734606 | 120.6 | KG | 121001.335 | Peru | NEW YORK JOHN F KENNEDY APT | SANOFI PASTEUR INC |